COVID-19
Coronavirus disease 2019 (COVID-19) is a contagious disease caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The first known case was identified in Wuhan, China in December 2019. The disease has since spread worldwide, leading to an ongoing pandemic.

Symptoms of COVID-19 are variable, but often include fever, cough, headache, fatigue, breathing difficulties, and loss of smell and taste. Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms. Of those people who develop noticeable symptoms enough to be classed as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% suffer critical symptoms (respiratory failure, shock, or multiorgan dysfunction). Older people are at a higher risk of developing severe symptoms. Some people continue to experience a range of effects (long COVID) for months after recovery, and damage to organs has been observed. Multi-year studies are underway to further investigate the long-term effects of the disease.

Transmission of COVID-19 occurs when people are exposed to virus-containing respiratory droplets and airborne particles exhaled by an infected person. Those particles may be inhaled or may reach the mouth, nose, or eyes of a person through touching or direct deposition (i.e. being coughed on). The risk of infection is highest when people are in close proximity for a long time, but particles can be inhaled over longer distances, particularly indoors in poorly ventilated and crowded spaces. In those conditions small particles can remain suspended in the air for minutes to hours. Touching a contaminated surface or object may lead to infection although this does not contribute substantially to transmission. People who are infected can transmit the virus to another person up to two days before they themselves show symptoms, as can people who do not experience symptoms. People remain infectious for up to ten days after the onset of symptoms in moderate cases and up to twenty days in severe cases.

Several testing methods have been developed to diagnose the disease. The standard diagnostic method is by detection of the virus' nucleic acid by real-time reverse transcription polymerase chain reaction (rRT-PCR), transcription-mediated amplification (TMA), or by reverse transcription loop-mediated isothermal amplification (RT-LAMP) from a nasopharyngeal swab.

Preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. The use of face masks or coverings has been recommended in public settings to minimize the risk of transmissions. 

While work is underway to develop drugs that inhibit the virus (and several vaccines for it have been approved and distributed in various countries, which have since initiated mass vaccination campaigns), the primary treatment is symptomatic. Management involves the treatment of symptoms, supportive care, isolation, and experimental measures.
Q2995419
contagious disease
Concept
Q82069695
severe acute respiratory syndrome coronavirus 2
Concept
Q11746
Wuhan
LOC
Q148
China
LOC
Q81068910
ongoing pandemic
Concept
Q104185125
Symptoms of COVID-19
UNK
Q188008
breathing difficulties
CEL
Q468433
loss of smell
Concept
Q606216
taste
Concept
Q193566
after exposure
Concept
Q1707292
do not develop noticeable symptoms
Concept
Q12192
pneumonia
Concept
Q188008
dyspnea
CEL
Q105688
hypoxia
Concept
Q767485
respiratory failure
Concept
Q178061
shock
Concept
Q1649580
multiorgan dysfunction
Concept
Q191089
Older people
Concept
Q100732653
long COVID
DIS
Q98456223
Transmission of COVID-19
CEL
Q5463769
respiratory droplet
Concept
Q381481
airborne
Concept
Q3075150
contaminated surface or object
Concept
Q86901049
testing methods
Concept
Q123619
nucleic acid
Concept
Q169526
real-time reverse transcription polymerase chain reaction
Concept
Q18353919
transcription-mediated amplification
UNK
Q18394182
reverse transcription loop-mediated isothermal amplification
PER
Q24210203
nasopharyngeal swab
Concept
Q88903302
Preventive measures
Concept
Q30314010
physical or social distancing
Concept
Q182899
quarantining
Concept
Q552461
hand washing
Concept
Q90416196
use of face masks or coverings
Concept
Q88459495
develop drugs
Concept
Q87719492
(and several vaccines
Concept
Q96391738
treatment
UNK
Q29483
treatment of symptoms
Concept
Q621558
supportive care
Concept
Q1674502
isolation
Concept
Q2752427
experimental measures
Concept
Q84263196
COVID-19
Concept
Q84263196
COVID-19
Concept
Q84263196
COVID-19
Concept
2019-01-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
2019
DATE
2019-12-01T00:00:00Z^^http://www.w3.org/2001/XMLSchema#dateTime
December 2019
DATE
-19^^http://www.w3.org/2001/XMLSchema#decimal
-19
NUMBER
+2^^http://www.w3.org/2001/XMLSchema#decimal
2
NUMBER
-2^^http://www.w3.org/2001/XMLSchema#decimal
-2
NUMBER
-19^^http://www.w3.org/2001/XMLSchema#decimal
-19
NUMBER
+81^^http://www.w3.org/2001/XMLSchema#decimal
81
NUMBER
+14^^http://www.w3.org/2001/XMLSchema#decimal
14
NUMBER
+50^^http://www.w3.org/2001/XMLSchema#decimal
50
NUMBER
+5^^http://www.w3.org/2001/XMLSchema#decimal
5
NUMBER
-19^^http://www.w3.org/2001/XMLSchema#decimal
-19
NUMBER
has cause
has cause
significant event
symptoms and signs
symptoms and signs
symptoms and signs
symptoms and signs
symptoms and signs
symptoms and signs
country
symptoms and signs